Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Jipei Liao"'
Publikováno v:
Thoracic Cancer, Vol 11, Iss 3, Pp 762-768 (2020)
Abstract Background The development of biomarkers for the early detection of non‐small cell lung cancer (NSCLC) is clinically important. We have developed miRNA biomarkers in sputum and plasma, respectively, for NSCLC. Herein, we evaluate whether i
Externí odkaz:
https://doaj.org/article/1210b95bcf2442bea8ed972010d195cc
Autor:
Huifen Zhou, Jipei Liao, Qixin Leng, Molangur Chinthalapally, Pushpa Dhilipkannah, Feng Jiang
Publikováno v:
Microorganisms, Vol 11, Iss 3, p 582 (2023)
Lung cancer is a leading cause of cancer deaths and early diagnosis can significantly improve outcomes. Pathogenic bacteria have been shown to play a role in tumorigenesis and its analysis provides a new approach for cancer diagnosis. To evaluate the
Externí odkaz:
https://doaj.org/article/32a3fcd4e33f4b3f85637d0059b52a92
Autor:
Zejia Yang, Jipei Liao, Brandon A. Carter-Cooper, Rena G. Lapidus, Kevin J. Cullen, Hancai Dan
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background We investigated the role of the ETS-1 transcription factor in Head and Neck Squamous Cell Carcinoma (HNSCC) in multiple cisplatin-resistant HNSCC cell lines. Methods We examined its molecular link with SRC and MEK/ERK pathways and
Externí odkaz:
https://doaj.org/article/b5fe2ee4171d4d008c916a2f7ab7acad
Autor:
Zejia Yang, Jipei Liao, Rena G. Lapidus, Xiaoxuan Fan, Ranee Mehra, Kevin J. Cullen, Hancai Dan
Publikováno v:
Cancer Chemotherapy and Pharmacology. 89:469-478
We investigated the role of Wee1 kinase in cisplatin-resistant head and neck squamous cell carcinoma (HNSCC) in multiple cisplatin-resistant HNSCC cell lines and determined the efficacy of either Wee1 inhibitor, AZD1775 alone, or in combination with
Publikováno v:
Cell Death Discovery, Vol 6, Iss 1, Pp 1-9 (2020)
Cell Death Discovery
Cell Death Discovery
Proto-oncogene tyrosine-protein kinase Src plays an important role in Head and Neck Squamous Cell Carcinoma (HNSCC). However, the FDA-approved SRC inhibitor Dasatinib shows very limited efficacy in HNSCC clinical trials, even though Dasatinib can com
Publikováno v:
Thoracic Cancer, Vol 11, Iss 3, Pp 762-768 (2020)
Thoracic Cancer
Thoracic Cancer
Background The development of biomarkers for the early detection of non-small cell lung cancer (NSCLC) is clinically important. We have developed miRNA biomarkers in sputum and plasma, respectively, for NSCLC. Herein, we evaluate whether integrated a
Autor:
Zejia Yang, Jipei Liao, Lisa Schumaker, Brandon Carter-Cooper, Rena G. Lapidus, Xiaoxuan Fan, Daria A. Gaykalova, Ranee Mehra, Kevin J. Cullen, Hancai Dan
Publikováno v:
Oral Oncology. 131:105939
To identify the most effective PI3K and EGFR inhibitors in HPV-positive head and neck squamous cell carcinoma (HNSCC) and investigate the efficacy of a combination of an ErbB family kinase inhibitor and a PI3K inhibitor to inhibit cell proliferation
Autor:
Hancai Dan, Rena G. Lapidus, Jipei Liao, Zhipeng Li, Zejia Yang, Kevin J. Cullen, Eun Yong Choi, Xuefeng Liu
Publikováno v:
British Journal of Cancer
Background Epidermal growth factor receptor (EGFR) plays an important role in head and neck squamous cell carcinoma (HNSCC) proliferation and therapy resistance, but the efficacy of targeting of EGFR for therapy has been limited. Here, we explore the
Autor:
Xuefeng Liu, Eun Yong Choi, Elizabeth T. Chang, Kevin J. Cullen, Rena G. Lapidus, Bhaskar Kallakury, Brandon Carter-Cooper, Hancai Dan, Jipei Liao, Zejia Yang
Publikováno v:
Clin Exp Metastasis
We explored the role of the transcription factor, NF-κB, and its upstream kinase IKKβ in regulation of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma (HNSCC). We showed that cisplatin-resistant HNSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbef1d61cba8074d6ee1624dff095a56
https://europepmc.org/articles/PMC7305835/
https://europepmc.org/articles/PMC7305835/
Publikováno v:
OncoTargets and therapy
Xiaoying Wang,1,2,* Jiefu Peng,2,3,* Jing Wang,4,* Miao Li,2 Di Wu,2 Songyan Wu,2 Jipei Liao,2 Jun Dou2 1Department of Basis Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, People’s Republic of China; 2Department of Pathogenic Biology